The Supportive Care and Symptom Management program supports studies on the prevention or treatment of acute and chronic symptoms and morbidities related to cancer and its treatment. This includes the impact on the quality of life of patients and their informal caregivers. The program also supports studies of patients and their caregivers at the end of life.
On This Page
- All Heading 2s will automatically be pulled in to this list.
- Do not edit the content on this template.
About Supportive Care and Symptom Management
The program supports research in three areas: prevention or treatment of acute or chronic symptoms and morbidities related to cancer, its treatment and caregiving (symptom management research); effects on quality of life from cancer, its treatment and caregiving (quality of life research); and end-of-life psychosocial issues, caregiving and treatment strategies (end-of-life research).
Through the NCI Community Oncology Research Program (NCORP), clinical trials are underway to evaluate therapies to prevent or ameliorate a broad range of symptoms and/or toxicities associated with cancer its treatment and caregiving. Other studies funded separately are investigating a range of treatment effects on health-related quality of life and a variety of influences on the end-of-life cancer experience.
Topic Areas include: Anorexia, Cachexia, Cardiotoxicity, Caregiver Issues, Cognitive Dysfunction, Distress/Anxiety/Depression, End of Life, Fatigue, Geriatrics, Hot Flashes, Lymphedema, Medication Adherence, Mucositis, Multiple Symptoms, Musculoskeletal Symptoms, Nausea, Neuropathy, Nutrition, Oral Complications, Other Supportive Care Issues, Pain, Palliative Care, Pediatrics/Adolescents/Young Adult, Physical Functioning, Quality of Life, Skin Toxicities, Sleep Disorders, and Urinary Complications.
Selected Topics
- HEAL Initiative
- Patient Resources on Side Effects of Cancer Treatment
- Patient Resources on Coping with Cancer
Resources
-
Building Bridges in Cancer Symptom Science Webinar SeriesThis series is aimed at bringing together interdisciplinary researchers in cancer symptom science to share their expertise and further discussions in the field.
-
DCP Early Career Scientist Spotlight Research Seminar SeriesThis seminar series highlights nominated early career scientists who are advancing research within the areas supported by DCP.
Funding Opportunities
No matching Funding Opportunities were found.
Grantee Details
Clinical Trials
| Title Sort descending | Intervention | Sponsor | Status |
|---|---|---|---|
| Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer | Duloxetine, Duloxetine Hydrochloride, Oxaliplatin, Placebo, Quality-of-Life Assessment, Questionnaire Administration | Alliance for Clinical Trials in Oncology | Active, not recruiting |
| E-Mindfulness Approaches for Living After Breast Cancer | Meditation Only Control Group, Mindfulness (MAPs) Digital App, Mindfulness (MAPs) Live Online | NRG Oncology | Recruiting |
| Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment | Assessment of Therapy Complications, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration | Children's Oncology Group | Recruiting |
| Engage Psychosocial Intervention for Cancer Symptoms | ENGAGE, Supportive Care | Duke University | Recruiting |
| Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors | Biospecimen Collection, Quality-of-Life Assessment, Questionnaire Administration | ECOG-ACRIN Cancer Research Group | Recruiting |
| Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT | Blood Specimen Collection, Quality of Life (QOL) Questionnaires, Stool Specimen Collection | University of California, San Francisco | Recruiting |
| Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment | Quality-of-Life Assessment, Questionnaire Administration | ECOG-ACRIN Cancer Research Group | Active, not recruiting |
| Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors | Biospecimen Collection, Fisetin, Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration | Jonsson Comprehensive Cancer Center | Recruiting |
| Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer | Androgen deprivation therapy, Flibanserin 100 MG, Placebo | Andrew McDonald | Active, not recruiting |
| Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors | Laboratory Biomarker Analysis, Questionnaire Administration | Children's Oncology Group | Active, not recruiting |
News and Events
Personalised Risk in Lung Screening
Date Posted: April 24, 2025
Cancer Cachexia: From Preclinical Models to Bedside Interventions
Date Posted: March 25, 2025
Survivorship in Patients with Multiple Myeloma Treated with Chimeric Antigen Receptor T-Cell Therapy
Date Posted: March 25, 2025